Main
Portfolio Index > 2004 Genetic
Index > GENETIC MANIPULATION PORTFOLIO
NIDA GENETIC MANIPULATION Portfolio Listing A - Z
| |
|
 |

|
| |
|
 |
| BAINTON, ROLAND |
A
GENETIC STUDY OF DROSOPHILA RESPONSES TO COCAINE |
| |
5K08DA000481-04 |
| |
|
| BARR, GORDON |
Neurobehavioral
studies of opiate drugs in development |
| |
2K02DA000325-06A1 |
| |
|
| BARTH, ALISON |
Experience
Dependent Plasticity in a fosGFP Mouse |
| |
1R01DA017188-01 |
| |
|
| BASKFIELD, CASSANDRA |
Drug
Discrimination in CB1 Null Mutant & Wild Type Mice |
| |
5F31DA014823-02 |
| |
|
| BASS, CAROLINE |
RNA
Interference to MAPK Events in delta9-THC Tolerance |
| |
1F32DA017543-01 |
| |
|
| BEAUDET, ARTHUR |
CORE--MOUSE
GENETICS |
| |
5P01DA012661-059001 |
| |
|
| BLAKELY, RANDY |
REGULATION
OF SEROTONIN TRANSPORTERS |
| |
5R01DA007390-14 |
| |
|
| BLENDY, JULIE |
GENETIC
ANALYSIS OF DRUG ADDICTION |
| |
5R01DA011649-04 |
| |
|
| BOHN, LAURA |
Morphine
Tolerance in Barrestin-2 KO Mice: Beyond Pain |
| |
7K01DA014600-03 |
| |
|
| BUCK, KARI |
GENETIC
VULNERABILITY TO DRUGS OF ABUSE |
| |
5R01DA005228-14 |
| |
|
| BURNETTE, JAMES |
CIRCADIAN GENE MODULATION OF COCAINE RESPONSIVENESS |
| |
5F32DA014446-03 |

|
| |
|
 |
| CADET, JEAN |
Molecular
Neurotoxicological Models Of Parkinsonism |
| |
1Z01DA000388-07 |
| |
|
| CAINE, SIMON |
COCAINE
SELF ADMINISTRATION IN DOPAMINE KNOCKOUT MICE |
| |
5R29DA012142-05 |
| |
|
| CARLEZON, WILLIAM |
BIOBEHAVIORAL
MECHANISMS OF DRUG REWARD AND ADDICTION |
| |
5R01DA012736-03 |
| |
|
| CARON, MARC |
GENETIC
ANALYSIS OF DOPAMINERGIC REWARD MECHANISMS |
| |
5R01DA013511-04 |
| |
|
| CASTILLO, PABLO |
Presynaptic
Forms of Long-Term Plasticity in the CNS |
| |
1R01DA017392-01 |
| |
|
| CHAVKIN, CHARLES |
Opioid
mediation of stress-potentiated cocaine response |
| |
1R01DA016898-01 |
| |
|
| CHAVKIN, CHARLES |
Molecular
Components Underlying Drug Abuse |
| |
5P01DA015916-02 |
| |
|
| CHAVKIN, CHARLES |
ENDOGENOUS
OPIOID PEPTIDE ACTION IN THE HIPPOCAMPUS |
| |
5R01DA004123-14 |
| |
|
| COLLINS, ALLAN |
Studies
with Nicotinic Null Mutant Mice |
| |
1P30DA015663-01 |
| |
|
| COLLINS, ALLAN |
GENETICS
OF NICOTINE TOLERANCE: ROLE OF RECEPTORS |
| |
5R01DA003194-21 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |

|
| |
|
 |
| HE, ZHIGANG |
Signaling
Mechanisms mediating effects of Semaphorin3A |
| |
5R01DA015335-03 |
| |
|
| HEN, RENE |
HALLUCINOGEN
EFFECTS IN 5HT2A RECEPTOR MUTANT MICE |
| |
5P01DA012923-040003 |
| |
|
| HEN, RENE |
DRUGS
OF ABUSE IN SEROTONIN RECEPTORS KNOCKOUT MICE |
| |
5R01DA009862-08 |
| |
|
| HIROI, NOBORU |
INTRACELLULAR
MOLECULES OF NICOTINE ADDICTION |
| |
5R01DA013232-04 |
| |
|
| HIRSH, JAY |
Non-invasive
self administration methodology for mice |
| |
1R21DA017696-01 |
| |
|
| HOFFER, BARRY |
Bradykinin
receptor agonist facilitates low-dose Cyclosp |
| |
1Z01DA000436-03 |
| |
|
| HOFFER, BARRY |
Effects
Of Cerebral Ischemia In Mice Deficient In Persep |
| |
1Z01DA000452-01 |
| |
|
| HOFFER, BARRY |
The
Noradrenergic System Of Aged Gdnf Heterozygous Mice |
| |
1Z01DA000453-01 |
| |
|
| HOFFER, BARRY |
Park2,
A Parkinson Candidate Gene, Mapped To The Telomer |
| |
1Z01DA000454-01 |
| |
|
| HOFFER, BARRY |
Aav-gdnf
Promotes Recovery Of Dopaminergic Phenotype Aft |
| |
1Z01DA000455-01 |
| |
|
| HOLMES, TODD |
Transgenic
Electrical Silencing of a Neural Circuit |
| |
5R21DA016352-02 |
| |
|
| HONDA, CHRISTOPHER |
Purinergic
Mechansism of Nociception |
| |
1R21DA017743-01 |
| |
|
| HOOK, VIVIAN |
Proteomics/Genomics
of Opiate Analgesia and Addiction |
| |
1R21DA015532-01A1 |

|
| |
|
 |

|
| |
|
 |
No Names at this time.

|
| |
|
 |

|
| |
|
 |
| LARGAESPADA, DAVID |
Transposon
Mediated Insertional Mutagenesis in Mice |
| |
1R01DA014764-01A1 |
| |
|
| LESLIE, FRANCES |
Nicotine
Regulation of Developing Brain Catecholamines |
| |
5R01DA010612-06 |
| |
|
| LESTER, HENRY |
Biogenic
Amine Transporters-Structure/Function |
| |
2R01DA009121-09 |
| |
|
| LEVITT, PAT |
FETAL
COCAINE AND GENE EXPRESSION DEFECTS IN FOREBRAIN |
| |
7R01DA013792-03 |
| |
|
| LEWIS, DEBORAH |
Brain
Cannabinoid Receptor Signaling and Pharmacology |
| |
5R01DA010350-06 |
| |
|
| LI, NING |
Purification
of Cannabinoid Receptors Type 1 and 2 |
| |
1R43DA016476-01 |
| |
|
| LIANG, YIQING |
High
throughout phenotypic screen: drug effects on home |
| |
2R44DA014889-02A1 |
| |
|
| LOH, HORACE |
Center
on Molecular and Cell Biology of Drug Abuse |
| |
2P50DA011806-06 |
| |
|
| LOH, HORACE |
NEUROCHEMICAL
BASIS OF NARCOTIC ADDICTION |
| |
5R01DA000564-31 |
| |
|
| LOH, HORACE |
STRUCTURAL
AND FUNCTIONAL STUDIES OF MU OPIOID RECEPTOR |
| |
5R01DA001583-26 |
| |
|
| LOW, MALCOLM |
Operant
Responding in Opioid-Deficient Mice |
| |
5R21DA014203-02 |

|
| |
|
 |

|
| |
|
 |
| NAGY, ANDRAS |
New
Directions in Mutagenized ES Cell Libraries |
| |
5R01DA014784-03 |
| |
|
| NAIRN, ANGUS |
DARPP-16 & DARPP-21
IN MEDIATING THE ACTIONS OF DRUGS OF ABUSE |
| |
5P01DA010044-080003 |
| |
|
| NESTLER, ERIC |
MOLECULAR
NEUROBIOLOGY OF DRUG ADDICTION |
| |
2P01DA008227-12 |
| |
|
| NESTLER, ERIC |
MOLECULAR
AND CELLULAR BASIS OF OPIATE ACTION |
| |
2P01DA008227-120001 |
| |
|
| NESTLER, ERIC |
Core--Transgenic |
| |
2P01DA008227-129001 |
| |
|
| NESTLER, ERIC |
MOLECULAR
STUDIES OF OPIATE AND COCAINE ACTION IN BRAIN |
| |
5K05DA000404-06 |
| |
|
| NESTLER, ERIC |
NEUROTROPHIC
FACTORS AND DRUGS OF ABUSE |
| |
5R01DA014133-04 |
| |
|
| NESTLER, ERIC |
MOLECULAR
STUDIES OF COCAINE ACTION IN BRAIN |
| |
5R37DA007359-14 |
| |
|
| NESTLER, ERIC |
Basic
Science Training Program in Drug Abuse |
| |
T32DA007290-11 |
| |
|
| NEUMAIER, JOHN |
The
Role of Serotonin Receptors In Brain Reward Circuits |
| |
1R01DA016432-01A1 |
| |
|
| NICHOLS, RUTHANN |
Novel
Genes Involved in Drug Response |
| |
5R21DA014901-02 |

|
| |
|
 |

|
| |
|
 |
| PAN, YING-XIAN |
Characterizing
a novel promoter of mouse MOR-1 gene |
| |
5R01DA013997-02 |
| |
|
| PASTERNAK, GAVRIL |
Synthesis & Pharmacology
of Novel Opiates and Systems |
| |
2R01DA006241-14A1 |
| |
|
| PASTERNAK, GAVRIL |
OPIATE
RECEPTOR PHARMACOLOGY |
| |
5K05DA000220-10 |
| |
|
| PASTERNAK, GAVRIL |
BIOCHEMICAL
CHARACTERIZATION OF OPIOID BINDING SITES |
| |
5R01DA002615-24 |
| |
|
| PASTERNAK, GAVRIL |
PHARMACOLOGY
OF OPIOID RECEPTOR SUBTYPES |
| |
5R37DA007242-13 |
| |
|
| PATRICK, JAMES |
MOLECULAR
APPROACHES TO NICOTINE ADDICTION |
| |
5R37DA004077-16 |
| |
|
| PETERSON, ANDREW |
Defective
Forebrain Development in Mutant Mice |
| |
9R01DA017627-06A2 |
| |
|
| PICCIOTTO, MARINA |
Galanin-opiate
interactions |
| |
1R01DA015425-01A1 |
| |
|
| PICCIOTTO, MARINA |
ROLE
OF THE HIGH AFFINITY NICOTINE RECEPTOR IN ADDICTION |
| |
5K02DA000436-05 |
| |
|
| PICCIOTTO, MARINA |
ANIMAL
MODELS OF RISK FACTORS FOR RELAPSE TO SMOKING |
| |
5P50DA013334-050001 |
| |
|
| PICCIOTTO, MARINA |
Anatomical
basis for nicotine addiction in mice |
| |
5R01DA014241-03 |
| |
|
| PICCIOTTO, MARINA |
NICOTINE
ADDICTION IN MICE LACKING THE NEURONAL NACHR |
| |
5R29DA010455-08 |
| |
|
| PICKEL, VIRGINIA |
EM-Transmitter
Interactions of Striatal Opioid Neurons |
| |
2R01DA004600-14A2 |
| |
|
| PINTAR, JOHN |
Gene
array analysis of opioid system mutant mice |
| |
5R01DA015237-02 |
| |
|
| PRUITT, STEVEN |
Development
of a high throughput gene trap vetor |
| |
5R01DA014773-03 |

|
| |
|
 |

|
| |
|
 |
| SANNA, PIETRO |
Role
of proteoglycans in cocaine dependence |
| |
1R21DA017208-01 |
| |
|
| SCHAFER, WILLIAM |
Analysis
of Touch Response & Habituation in C. elegans |
| |
1R01DA016445-01 |
| |
|
| SCHAFER, WILLIAM |
GENETIC
ANALYSIS OF NICOTINE ADAPTATION IN C ELEGANS |
| |
5R01DA012891-04 |
| |
|
| SCHAFER, WILLIAM |
Machine
vision analysis of nematode behavioral patterns. |
| |
5R21DA015823-02 |
| |
|
| SCHOFFELMEER, ANTON |
GENE
EXPRESSION PATTERNS DURING HEROIN SEEKING BEHAVIOR |
| |
5R01DA013768-03 |
| |
|
| SCHRAMM, NICOLE |
Roles
of PKA in Addiction |
| |
5F32DA014151-03 |
| |
|
| SCHWARZSCHILD, MICHAEL |
A2A
Adenosine Receptors in Psychostimulant Sensitization |
| |
5R01DA013508-03 |
| |
|
| SEALFON, STUART |
CELLULAR
RESPONSES TO HALLUCINOGENS |
| |
5P01DA012923-040002 |
| |
|
| SEDORE, STACEY |
COCAINE-SENSITIVE
REGULATION DURING DROSOPHILA OOGENESIS |
| |
5F31DA006063-03 |
| |
|
| SELF, DAVID |
NEUROADAPTATIONS
IN DRUG SELF-ADMINISTRATION AND RELAPSE |
| |
2P01DA008227-120004 |
| |
|
| SELF, DAVID |
Core--Behavioral |
| |
2P01DA008227-129002 |
| |
|
| SELF, DAVID |
Regulation
of Addictive Behavior by Dopamine Signaling |
| |
5R01DA010460-09 |
| |
|
| SMALHEISER, NEIL |
RNAi-Mediated
Gene Suppression in Adult Mammalian CNS |
| |
5R21DA015450-02 |
| |
|
| SMITH, AUSTIN |
Precision
Transgenesis Rats via Embryonic Cells Lines |
| |
1R01DA015943-01 |
| |
|
| SNODDY, JAY |
Bioinfomatics
for Mouse Phenotype Analysis |
| |
5P01DA015027-02 |
| |
|
| SNYDER, GRETCHEN |
DRUGS
OF ABUSE: ROLE OF Cdk5 IN THE ACTIONS OF PSYCHOSTIMULANTS |
| |
5P01DA010044-080001 |
| |
|
| SNYDER, SOLOMON |
NEUROTRANSMITTER
RECEPTORS |
| |
5K05DA000074-24 |
| |
|
| SNYDER, SOLOMON |
Drug
Abuse Research Center |
| |
5P50DA000266-32 |
| |
|
| STITZEL, JERRY |
Identification
of Functional nAChR Variants in Mice |
| |
5R01DA014369-03 |

|
| |
|
 |
|
| |
|
| |
|
 |
| |